Cover Image
市場調查報告書

關節內粘稠補充療法:開發中產品分析

Viscosupplementation - Pipeline Review, 2015

出版商 GlobalData 商品編碼 334920
出版日期 內容資訊 英文 37 Pages
訂單完成後即時交付
價格
Back to Top
關節內粘稠補充療法:開發中產品分析 Viscosupplementation - Pipeline Review, 2015
出版日期: 2015年06月10日 內容資訊: 英文 37 Pages
簡介

本報告提供目前開發中的關節內粘稠補充療法的開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 關節內粘稠補充療法概要

第3章 開發中的產品

  • 關節內粘稠補充療法 - 開發中產品:各開發階段
  • 關節內粘稠補充療法 - 開發中產品:各地區
  • 關節內粘稠補充療法 - 開發中產品:各法規途徑
  • 關節內粘稠補充療法 - 開發中產品:各核準時期 (預定)
  • 關節內粘稠補充療法 - 進行中的臨床實驗

第4章 關節內粘稠補充療法:正在開發的開發中產品 (各企業)

  • 關節內粘稠補充療法企業 - 開發中產品:各開發階段
  • 關節內粘稠補充療法 - 開發中產品:各開發階段

第5章 關節內粘稠補充療法企業與產品概要

  • Anika Therapeutics, Inc.
  • BioPolymer GmbH & Co. KG
  • Carbylan Therapeutics, Inc.
  • Chi2Gel Ltd.
  • Cocoon Biotech, Inc.
  • Flex Biomedical, Inc.
  • Moebius Medical Ltd.
  • OrthogenRx Inc.
  • Synolyne Pharma
  • University of Kansas

第6章 關節內粘稠補充療法:最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0031EPD

GlobalData's Medical Devices sector report, "Viscosupplementation - Pipeline Review, 2015" provides an overview of Viscosupplementation currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type

Scope

  • Extensive coverage of the Viscosupplementation under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Viscosupplementation and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Viscosupplementation under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Viscosupplementation Overview

3. Products under Development

  • 3.1. Viscosupplementation - Pipeline Products by Stage of Development
  • 3.2. Viscosupplementation - Pipeline Products by Territory
  • 3.3. Viscosupplementation - Pipeline Products by Regulatory Path
  • 3.4. Viscosupplementation - Pipeline Products by Estimated Approval Date
  • 3.5. Viscosupplementation - Ongoing Clinical Trials

4. Viscosupplementation - Pipeline Products under Development by Companies

  • 4.1. Viscosupplementation Companies - Pipeline Products by Stage of Development
  • 4.2. Viscosupplementation - Pipeline Products by Stage of Development

5. Viscosupplementation Companies and Product Overview

  • 5.1. Anika Therapeutics, Inc. Company Overview
    • 5.1.1. Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. BioPolymer GmbH & Co. KG Company Overview
    • 5.2.1. BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Carbylan Therapeutics, Inc. Company Overview
    • 5.3.1. Carbylan Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Chi2Gel Ltd. Company Overview
    • 5.4.1. Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Cocoon Biotech, Inc. Company Overview
    • 5.5.1. Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Flex Biomedical, Inc. Company Overview
    • 5.6.1. Flex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Moebius Medical Ltd. Company Overview
    • 5.7.1. Moebius Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. OrthogenRx Inc. Company Overview
    • 5.8.1. OrthogenRx Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Synolyne Pharma Company Overview
    • 5.9.1. Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. University of Kansas Company Overview
    • 5.10.1. University of Kansas Pipeline Products & Ongoing Clinical Trials Overview

6. Viscosupplementation- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Viscosupplementation - Pipeline Products by Stage of Development
  • Table 2: Viscosupplementation - Pipeline Products by Territory
  • Table 3: Viscosupplementation - Pipeline Products by Regulatory Path
  • Table 4: Viscosupplementation - Pipeline Products by Estimated Approval Date
  • Table 5: Viscosupplementation - Ongoing Clinical Trials
  • Table 6: Viscosupplementation Companies - Pipeline Products by Stage of Development
  • Table 7: Viscosupplementation - Pipeline Products by Stage of Development
  • Table 8: Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Cingal - Product Status
  • Table 10: Cingal - Product Description
  • Table 11: Anika Therapeutics, Inc. - Ongoing Clinical Trials Overview
  • Table 12: Cingal - To Evaluate the Safety of a Repeat Injection of Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee (Cingal 13-02: An Open-label, Follow-on Study to Cingal 13-01)
  • Table 13: BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Crespine Gel - Product Status
  • Table 15: Crespine Gel - Product Description
  • Table 16: Crespine Gel Plus - Product Status
  • Table 17: Crespine Gel Plus - Product Description
  • Table 18: Carbylan Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: Hydros - Product Status
  • Table 20: Hydros - Product Description
  • Table 21: Hydros TA - Product Status
  • Table 22: Hydros TA - Product Description
  • Table 23: Hydros TA - Hip - Product Status
  • Table 24: Hydros TA - Hip - Product Description
  • Table 25: Carbylan Therapeutics, Inc. - Ongoing Clinical Trials Overview
  • Table 26: Hydros - A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated wWith Osteoarthritis in the Knee
  • Table 27: Hydros TA - A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated wWith Osteoarthritis in the Knee
  • Table 28: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Chi2Knee - Product Status
  • Table 30: Chi2Knee - Product Description
  • Table 31: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Silk Hydrogel - Product Status
  • Table 33: Silk Hydrogel - Product Description
  • Table 34: Flex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Flex Polymer - Product Status
  • Table 36: Flex Polymer - Product Description
  • Table 37: Moebius Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: MM-II - Product Status
  • Table 39: MM-II - Product Description
  • Table 40: OrthogenRx Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: OrthogenRx Device - Product Status
  • Table 42: OrthogenRx Device - Product Description
  • Table 43: Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Arthrovisc - Product Status
  • Table 45: Arthrovisc - Product Description
  • Table 46: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: 3-D Colloidal Gel - Product Status
  • Table 48: 3-D Colloidal Gel - Product Description
  • Table 49: Glossary

List of Figures

  • Figure 1: Viscosupplementation - Pipeline Products by Stage of Development
  • Figure 2: Viscosupplementation - Pipeline Products by Territory
  • Figure 3: Viscosupplementation - Pipeline Products by Regulatory Path
  • Figure 4: Viscosupplementation - Pipeline Products by Estimated Approval Date
  • Figure 5: Viscosupplementation - Ongoing Clinical Trials
Back to Top